BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 25074765)

  • 1. Statin treatment reduces the risk of hepatocellular carcinoma but not colon cancer-results from a nationwide case-control study in Sweden.
    Björkhem-Bergman L; Backheden M; Söderberg Löfdal K
    Pharmacoepidemiol Drug Saf; 2014 Oct; 23(10):1101-6. PubMed ID: 25074765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of statin on hepatocellular carcinoma in patients with type 2 diabetes: A nationwide nested case-control study.
    Kim G; Jang SY; Han E; Lee YH; Park SY; Nam CM; Kang ES
    Int J Cancer; 2017 Feb; 140(4):798-806. PubMed ID: 27861855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statin use and the risk of hepatocellular carcinoma in patients at high risk: A nationwide nested case-control study.
    Kim G; Jang SY; Nam CM; Kang ES
    J Hepatol; 2018 Mar; 68(3):476-484. PubMed ID: 29107150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statin and the risk of hepatocellular carcinoma and death in a hospital-based hepatitis B-infected population: A propensity score landmark analysis.
    Hsiang JC; Wong GL; Tse YK; Wong VW; Yip TC; Chan HL
    J Hepatol; 2015 Nov; 63(5):1190-7. PubMed ID: 26208777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipophilic Statins and Risk for Hepatocellular Carcinoma and Death in Patients With Chronic Viral Hepatitis: Results From a Nationwide Swedish Population.
    Simon TG; Duberg AS; Aleman S; Hagstrom H; Nguyen LH; Khalili H; Chung RT; Ludvigsson JF
    Ann Intern Med; 2019 Sep; 171(5):318-327. PubMed ID: 31426090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statin use and risk of prostate cancer: a Danish population-based case-control study, 1997-2010.
    Jespersen CG; Nørgaard M; Friis S; Skriver C; Borre M
    Cancer Epidemiol; 2014 Feb; 38(1):42-7. PubMed ID: 24275259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statin use and risk of hepatocellular carcinoma in a U.S. population.
    McGlynn KA; Divine GW; Sahasrabuddhe VV; Engel LS; VanSlooten A; Wells K; Yood MU; Alford SH
    Cancer Epidemiol; 2014 Oct; 38(5):523-7. PubMed ID: 25113938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statins are associated with a reduced risk of hepatocellular carcinoma in a large cohort of patients with diabetes.
    El-Serag HB; Johnson ML; Hachem C; Morgana RO
    Gastroenterology; 2009 May; 136(5):1601-8. PubMed ID: 19208359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statin use and risk of hepatocellular carcinoma.
    Lai SW; Liao KF; Lai HC; Muo CH; Sung FC; Chen PC
    Eur J Epidemiol; 2013 Jun; 28(6):485-92. PubMed ID: 23681775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statin Use is Associated with Decreased Hepatocellular Carcinoma Recurrence in Liver Transplant Patients.
    Cho Y; Kim MS; Nam CM; Kang ES
    Sci Rep; 2019 Feb; 9(1):1467. PubMed ID: 30728421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of aspirin and statin use with the risk of liver cancer in chronic hepatitis B: A nationwide population-based study.
    Choi WM; Kim HJ; Jo AJ; Choi SH; Han S; Ko MJ; Lim YS
    Liver Int; 2021 Nov; 41(11):2777-2785. PubMed ID: 34242482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statin use and risk of colorectal cancer.
    Coogan PF; Smith J; Rosenberg L
    J Natl Cancer Inst; 2007 Jan; 99(1):32-40. PubMed ID: 17202111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A population-based case-control study on statin exposure and risk of acute diverticular disease.
    Sköldberg F; Svensson T; Olén O; Hjern F; Schmidt PT; Ljung R
    Scand J Gastroenterol; 2016; 51(2):203-10. PubMed ID: 26357870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statin use and risk for ovarian cancer: a Danish nationwide case-control study.
    Baandrup L; Dehlendorff C; Friis S; Olsen JH; Kjær SK
    Br J Cancer; 2015 Jan; 112(1):157-61. PubMed ID: 25393364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statins and the risk of hepatocellular carcinoma in patients with hepatitis C virus infection.
    Tsan YT; Lee CH; Ho WC; Lin MH; Wang JD; Chen PC
    J Clin Oncol; 2013 Apr; 31(12):1514-21. PubMed ID: 23509319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statins and the risk of hepatocellular carcinoma in patients with hepatitis B virus infection.
    Tsan YT; Lee CH; Wang JD; Chen PC
    J Clin Oncol; 2012 Feb; 30(6):623-30. PubMed ID: 22271485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statin therapy and the risk of intracerebral haemorrhage: a nationwide observational study.
    Åsberg S; Eriksson M
    Int J Stroke; 2015 Oct; 10 Suppl A100():46-9. PubMed ID: 26043664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statin use and the risk of esophageal cancer: a population-based case-control study.
    Chan TF; Chiu HF; Wu CH; Lin CL; Yang CY
    Expert Opin Drug Saf; 2013 May; 12(3):293-8. PubMed ID: 23470154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination Therapy of Metformin and Statin May Decrease Hepatocellular Carcinoma Among Diabetic Patients in Asia.
    Chen HH; Lin MC; Muo CH; Yeh SY; Sung FC; Kao CH
    Medicine (Baltimore); 2015 Jun; 94(24):e1013. PubMed ID: 26091447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statin use and risk of COPD exacerbation requiring hospitalization.
    Wang MT; Lo YW; Tsai CL; Chang LC; Malone DC; Chu CL; Liou JT
    Am J Med; 2013 Jul; 126(7):598-606.e2. PubMed ID: 23684060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.